North Star Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

North Star Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$112K	Sell	3,311 -40	-1%	-$1.33K	0.01%	590
2026 Q1	$101K	Sell	3,351 -81	-2%	-$2.61K	0.01%	602
2025 Q4	$107K	Buy	3,432 +87	+3%	+$2.14K	0.01%	538
2025 Q3	$67.6K	Buy	3,345 +20	+0.6%	+$351	﹤0.01%	598
2025 Q2	$55.7K	Hold	3,325	–	–	﹤0.01%	613
2025 Q1	$51.1K	Hold	3,325	–	–	﹤0.01%	609
2024 Q4	$73.3K	Hold	3,325	–	–	0.01%	560
2024 Q3	$59.9K	Hold	3,325	–	–	﹤0.01%	575
2024 Q2	$54K	Hold	3,325	–	–	﹤0.01%	591
2024 Q1	$46.9K	Hold	3,325	–	–	﹤0.01%	619
2023 Q4	$34.7K	Sell	3,325 -140	-4%	-$1.31K	﹤0.01%	647
2023 Q3	$35.3K	Buy	3,465 +700	+25%	+$6.52K	﹤0.01%	651
2023 Q2	$20.8K	Hold	2,765	–	–	﹤0.01%	737
2023 Q1	$24.5K	Hold	2,765	–	–	﹤0.01%	733
2022 Q4	$25.2K	Hold	2,765	–	–	﹤0.01%	704
2022 Q3	$22K	Hold	2,765	–	–	﹤0.01%	684
2022 Q2	$21K	Buy	2,765 +500	+22%	+$4.36K	﹤0.01%	707
2022 Q1	$21K	Hold	2,265	–	–	﹤0.01%	736
2021 Q4	$18K	Hold	2,265	–	–	﹤0.01%	791
2021 Q3	$22K	Buy	2,265 +50	+2%	+$468	﹤0.01%	727
2021 Q2	$22K	Buy	2,215 +1,015	+85%	+$10.7K	﹤0.01%	730
2021 Q1	$14K	Sell	1,200 -20	-2%	-$229	﹤0.01%	741
2020 Q4	$12K	Sell	1,220 -8	-0.7%	-$77	﹤0.01%	752
2020 Q3	$11K	Hold	1,228	–	–	﹤0.01%	738
2020 Q2	$15K	Hold	1,228	–	–	﹤0.01%	670
2020 Q1	$11K	Sell	1,228 -200	-14%	-$2.05K	﹤0.01%	710
2019 Q4	$14K	Buy	1,428 +624	+78%	+$5.57K	﹤0.01%	771
2019 Q3	$6K	Buy	+804	New	+$6.16K	﹤0.01%	904
2019 Q2	–	Sell	-804	Closed	-$13K	–	874
2019 Q1	$13K	Hold	804	–	–	﹤0.01%	789
2018 Q4	$12K	Buy	804 +276	+52%	+$5.66K	﹤0.01%	778
2018 Q3	$11K	Buy	528 +200	+61%	+$4.64K	﹤0.01%	832
2018 Q2	$8K	Hold	328	–	–	﹤0.01%	895
2018 Q1	$6K	Sell	328 -693	-68%	-$13.5K	﹤0.01%	924
2017 Q4	$19K	Sell	1,021 -3,030	-75%	-$45.6K	﹤0.01%	727
2017 Q3	$71K	Sell	4,051 -1,953	-33%	-$43.9K	0.01%	486
2017 Q2	$199K	Buy	6,004 +1,715	+40%	+$53.1K	0.03%	348
2017 Q1	$138K	Buy	4,289 +28	+0.7%	+$956	0.02%	373
2016 Q4	$154K	Sell	4,261 -15,007	-78%	-$599K	0.02%	350
2016 Q3	$887K	Sell	19,268 -12,650	-40%	-$660K	0.16%	159
2016 Q2	$1.6M	Buy	31,918 +6,350	+25%	+$338K	0.29%	100
2016 Q1	$1.37M	Hold	25,568	–	–	0.26%	110
2015 Q4	$1.68M	Buy	25,568 +4,000	+19%	+$247K	0.33%	89
2015 Q3	$1.22M	Buy	21,568 +5,000	+30%	+$324K	0.25%	113
2015 Q2	$979K	Buy	16,568 +13,083	+375%	+$807K	0.18%	148
2015 Q1	$217K	Hold	3,485	–	–	0.04%	272
2014 Q4	$200K	Hold	3,485	–	–	0.04%	272
2014 Q3	$187K	Hold	3,485	–	–	0.04%	263
2014 Q2	$183K	Buy	3,485 +560	+19%	+$28.6K	0.04%	269
2014 Q1	$155K	Buy	+2,925	New	+$135K	0.03%	285

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

North Star Investment Management's TEVA Position: Q2 2026 in Review

North Star Investment Management reduced its Teva Pharmaceuticals (TEVA) stake by 1.2% in Q2 2026, selling an estimated $1.33K and leaving 3,311 shares worth $112K. The position accounts for 0.01% of the portfolio, ranked #590.

North Star Investment Management first reported a position in TEVA in Q1 2014 and has held it in 49 quarters since. The position peaked at $1.68M in Q4 2015. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

North Star Investment Management held 3,311 shares of Teva Pharmaceuticals worth $112K as of Q2 2026.
North Star Investment Management sold 40 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.33K.
Teva Pharmaceuticals made up 0.01% of North Star Investment Management's portfolio in Q2 2026, its #590 holding.
North Star Investment Management first reported a position in Teva Pharmaceuticals in Q1 2014 and has held it in 49 quarters since.
North Star Investment Management's Teva Pharmaceuticals position peaked at $1.68M in Q4 2015.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.